Condition
Healthy Participants Study clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Healthy Participants Study clinical trials that are recruiting, at sites in 4 countries (most in China (2), United States (1), Australia (1)). By phase: Phase 1 (4), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Healthy Participants Study clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safe, blood-and-fluid study of ALZ-507 in healthy adults 50–75 | Phase 1 | Miami, Florida | Recruiting | Sep 17, 2026 |
| ZL-65 tablet in healthy adults: safety, tolerability, and pharmacokinetics in China | Phase 1 | Chengdu, Sichuan | Recruiting | Aug 11, 2026 |
| ZP6590 safety and dosing in adults with varying weight | Early Phase 1 | Neuss, North Rhine-Westphalia | Recruiting | Jul 23, 2026 |
| First-in-human test of CND319 in healthy people and people with rheumatic diseases | Phase 1 | Melbourne, Victoria | Recruiting | Jul 20, 2026 |
| BY002 safety in healthy adults: a first-in-human, randomized, placebo-controlled study | Phase 1 | Hangzhou, Zhejiang | Recruiting | Jun 10, 2026 |
All recruiting trials (5)
-
Safe, blood-and-fluid study of ALZ-507 in healthy adults 50–75
This study tests whether ALZ-507 is safe and how it behaves in the body of healthy adults aged 50 to 75.
-
ZL-65 tablet in healthy adults: safety, tolerability, and pharmacokinetics in China
This first‑in‑humans study tests whether a single dose of ZL‑65 is safe and well tolerated in healthy adults in China and looks at how the body handles the drug, including the effect of food on absorption.
-
ZP6590 safety and dosing in adults with varying weight
This study tests ZP6590 in adults with normal weight, overweight, and obesity to see if it is safe and tolerable and to understand how the drug behaves in the body.
-
First-in-human test of CND319 in healthy people and people with rheumatic diseases
This early study tests whether CND319 is safe and tolerable and whether it shows any signs of activity in healthy adults and in people with rheumatoid arthritis or Sjogren's syndrome.
-
BY002 safety in healthy adults: a first-in-human, randomized, placebo-controlled study
This study tests BY002 against placebo to see if it is safe and tolerable in healthy adults.
Related topics
Quick answers
How many Healthy Participants Study clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), United States (1 trial), Australia (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.